Search

Your search keyword '"Eriika Savontaus"' showing total 67 results

Search Constraints

Start Over You searched for: Author "Eriika Savontaus" Remove constraint Author: "Eriika Savontaus"
67 results on '"Eriika Savontaus"'

Search Results

1. Melanocortin 1 receptor regulates cholesterol and bile acid metabolism in the liver

2. Single-Cell Proteomics Reveals the Defined Heterogeneity of Resident Macrophages in White Adipose Tissue

Catalog

Books, media, physical & digital resources

3. Peripherally Administered Y2-Receptor Antagonist BIIE0246 Prevents Diet-Induced Obesity in Mice With Excess Neuropeptide Y, but Enhances Obesity in Control Mice

4. Neuropeptide Y in the noradrenergic neurons induces the development of cardiometabolic diseases in a transgenic mouse model

5. Neuropeptide Y Overexpressing Female and Male Mice Show Divergent Metabolic but Not Gut Microbial Responses to Prenatal Metformin Exposure.

6. α-MSH analogue attenuates blood pressure elevation in DOCA-salt hypertensive mice.

7. MMP-13 regulates growth of wound granulation tissue and modulates gene expression signatures involved in inflammation, proteolysis, and cell viability.

8. Metabolic regulation in progression to autoimmune diabetes.

9. α-Melanocyte-Stimulating Hormone Regulates Pathological Cardiac Remodeling by Activating Melanocortin 5 Receptor in Cardiomyocytes

10. Treatment with Soluble Activin Type IIB Receptor Ameliorates Ovariectomy-Induced Bone Loss and Fat Gain in Mice

11. Melanocortin 1 receptor regulates cholesterol and bile acid metabolism in the liver

12. The Effects of Neuropeptide Y Overexpression on the Mouse Model of Doxorubicin-Induced Cardiotoxicity

13. Seasonal variation in brain mu-opioid receptor availability

14. Hypothalamic γ-melanocyte stimulating hormone gene delivery reduces fat mass in male mice

15. Melanocortin 1 Receptor Deficiency Promotes Atherosclerosis in Apolipoprotein E −/− Mice

16. Effects of dexmedetomidine and MK-467 on plasma glucose, insulin and glucagon in a glibenclamide-induced canine hypoglycaemia model

17. Neuropeptide Y in noradrenergic neurons induces obesity in transgenic mouse models

18. Vimentin regulates Notch signaling strength and arterial remodeling in response to hemodynamic stress

19. Melanocortin overexpression limits diet-induced inflammation and atherosclerosis in LDLR

20. Deficiency in Melanocortin 1 Receptor Signaling Predisposes to Vascular Endothelial Dysfunction and Increased Arterial Stiffness in Mice and Humans

21. The metabolic syndrome in mice overexpressing neuropeptide Y in noradrenergic neurons

22. Neuropeptide Y in the noradrenergic neurones induces obesity and inhibits sympathetic tone in mice

23. Neuropeptide Y Attenuates Stress-Induced Bone Loss Through Suppression of Noradrenaline Circuits

24. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice

25. Lentivirus-Mediated α-Melanocyte-Stimulating Hormone Overexpression in the Hypothalamus Decreases Diet Induced Obesity in Mice

26. Genetic and pharmacological mouse models of chronic melanocortin activation show enhanced baroreflex control of heart rate

27. α-Melanocyte-stimulating hormone regulates vascular NO availability and protects against endothelial dysfunction

28. Involvement of α2-Adrenoceptor Subtypes A and C in Glucose Homeostasis and Adrenaline-Induced Hyperglycaemia

29. ENETS Newsletter Summer/Fall 2012

30. Neuropeptide Y in the noradrenergic neurons induces the development of cardiometabolic diseases in a transgenic mouse model

31. Melanocortin 1 receptor deficiency promotes atherosclerosis in Apolipoprotein E-/- mice

32. Acute hormonal changes following intravenous glucose challenge in lean and obese human subjects

33. Blood pressure regulation and cardiac autonomic control in mice overexpressing α- and γ-melanocyte stimulating hormone

34. Transgenic Mice Overexpressing Neuropeptide Y in Noradrenergic Neurons

35. Reduced blood glucose levels, increased insulin levels and improved glucose tolerance in α2A-adrenoceptor knockout mice

36. Effects of intravenous glucose on Dopaminergic function in the human brain in vivo

37. Effects of peripherally acting neuropeptide Y2 receptor antagonist BIIE0246 on obesity in mice

38. NPY overexpression in NTS induces hyperphagia and attenuates sympathetic tone

39. Diurnal rhythms of blood glucose, serum ghrelin, faecal IgA and faecal corticosterone in rats subjected to restricted feeding using the diet board

40. Effects of adrenalectomy on AGRP, POMC, NPY and CART gene expression in the basal hypothalamus of fed and fasted rats

41. α-MSH overexpression in the nucleus tractus solitarius decreases fat mass and elevates heart rate

42. Stress- and diet-induced fat gain is controlled by NPY in catecholaminergic neurons

43. Leptin Regulation ofAgrpandNpymRNA in the Rat Hypothalamus

44. Effects of Chronic Celiprolol Treatment on Brown Fat, Feeding, and Drinking in fa/fa Zucker Rats

45. Differential Regulation of Uncoupling Proteins by Chronic Treatments with β3-Adrenergic Agonist BRL 35135 and Metformin in Obesefa/faZucker Rats

46. Anti-obesity effect of MPV-1743 AIII, a novel imidazoline derivative, in genetic obesity

47. Chronic treatment with BRL 35135 potentiates the action of insulin on lipid metabolism

48. The effects of equal caloric high fat and western diet on metabolic syndrome, oxidative stress and vascular endothelial function in mice

49. Diet-Induced Obesity in Mice Overexpressing Neuropeptide Y in Noradrenergic Neurons

50. Involvement of α2-adrenoceptor subtypes A and C in glucose homeostasis and adrenaline-induced hyperglycaemia